Innovation Pharma’s clinical trial testing of brilacidin against COVID-19 targeted to commence in 2020 fourth quarter
On Jul. 13, 2020, Innovation Pharma announced that, in parallel to previously reported manufacturing efforts, the Company had…
On Jul. 13, 2020, Innovation Pharma announced that, in parallel to previously reported manufacturing efforts, the Company had…
On Jul. 13, 2020, an emerging virus threatens both wild and pet rabbits in the U.S. The fatal…
On Jul. 13, 2020, Altimmune announced positive results from the preclinical studies of its intranasal COVID-19 vaccine candidate,…
On Jul. 13, 2020, Bellerophon Therapeutics announced that the first patient has initiated treatment in the Companyï¾’s Phase…
On Jul. 13, 2020, Pfizer and BioNTech announced that two of the companiesï¾’ four investigational vaccine candidates from…
On Jul. 13, 2020, BioReference Laboratories, an OPKO Health company, announced that it would provide COVID-19 testing oversight…
On Jul. 13, 2020, Tonix Pharmaceuticals announced a new preclinical research and option agreement with Kansas State University…
On Jul. 13, 2020, Meridian Bioscience announced it had launched a high-sensitivity SARS-CoV-2 nucleocapsid antibody pair for the…
On Jul. 13, 2020, researchers from Virginia Tech and the NIH suggested that Bacille Calmette-Gu�rin (BCG), a tuberculosis…
On Jul. 12, 2020, Royal Philips announced an addition to its remote patient monitoring suite supporting at-risk populations…
On Jul. 10, 2020, Governor Doug Ducey announced a strategic collaboration with Sonora Quest Laboratories, the Arizona Department…
On Jul. 10, 2020, Gilead Sciences announced that a comparative analysis of the Phase 3 SIMPLE-Severe trial and…
On Jul. 10, 2020, the Imaging Platform at the Broad Institute of MIT and Harvard, together with industry…
On Jul. 10, 2020, researchers at UT Southwestern Medical Center and Texas Health Resources announced that they will…
On Jul. 9, 2020, a study from the NIH showed that neurofilament light chain (NfL) delivered superior diagnostic…
On Jul. 9, 2020, a study, published in the journal Cell Systems, laid out a new framework for…
On Jul. 9, 2020, the CDC reported that after a decade of increasing rates, contact sportsï¾–related TBI ED…
On Jul. 9, 2020, WHO announced the initiation of the Independent Panel for Pandemic Preparedness and Response (IPPR)…
On Jul. 9, 2020, Atos announced that the Biocomputing Unit at the Spanish National Center for Biotechnology (CNB),…
On Jul. 9, 2020, Royal Philips announced it had formed a strategic collaboration with BioIntelliSense, a continuous health…
On Jul. 9, 2020, BioSig Technologies and its subsidiary, ViralClear Pharma announced that it is partnering with Albany…
On Jul. 9, 2020 Moderna and Laboratorios Farmaceuticos Rovi announced a collaboration for large-scale, commercial fill-finish manufacturing of…
On Jul. 9, 2020, Altimmune announced that it had entered into a teaming agreement with DynPort Vaccine Company…
On Jul. 9, 2020, Pfizer announced it had pledged $100 million to the new Antimicrobial Resistance (AMR) Action…
On Jul. 9, 2020, BioReference Laboratories, an OPKO Health company, announced that it will conduct COVID-19 testing for…
On Jul. 9, 2020, Mylan and Fujifilm Kyowa Kirin Biologics announced the FDA had approved Hulioï¾® (adalimumab-fkjp), a…
On Jul. 8, 2020, research showed that adolescents who live in areas that have high levels of artificial…
On Jul. 8, 2020, the National Institute of Allergy and Infectious Diseases announced it had established a new…
On Jul. 8, 2020, scientists at the UC Berkeley-UCSF Joint Medical Program reported that for some individuals with…
On Jul. 8, 2020, seventy-three countries warned that they were at risk of stock-outs of antiretroviral (ARV) medicines…